Nymox Pharmaceutical raises $3M in private placement
Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Nymox Pharmaceutical Corp. raised $3 million through private placements with long-term stockholders.
Nymox said there were no warrants or fees in the transactions.
The company plans to use the proceeds for general corporate purposes.